Laddar...
Adoption of Sacubitril/Valsartan for the Management of Patients with Heart Failure
BACKGROUND: The United States Food and Drug Administration (FDA) approved the use of sacubitril/valsartan in patients with heart failure (HF) and reduced ejection fraction (HFrEF) in July 2015We aimed to assess the adoption and prescription drug costs of sacubitril/valsartan in its first 18 months f...
Sparad:
| I publikationen: | Circ Heart Fail |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5820776/ https://ncbi.nlm.nih.gov/pubmed/29453287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004302 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|